Cargando…
The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases
Receptor activator of NF-kB (RANK) pathway regulates bone remodeling and is involved in breast cancer (BC) progression. Genetic polymorphisms affecting RANK-ligand (RANKL) and osteoprotegerin (OPG) have been previously associated with BC risk and bone metastasis (BM)-free survival, respectively. In...
Autores principales: | Ferreira, Arlindo, Alho, Irina, Vendrell, Inês, Melo, Marta, Brás, Raquel, Costa, Ana Lúcia, Sousa, Ana Rita, Mansinho, André, Abreu, Catarina, Pulido, Catarina, Macedo, Daniela, Pacheco, Teresa, Correia, Lurdes, Costa, Luis, Casimiro, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173066/ https://www.ncbi.nlm.nih.gov/pubmed/27191503 http://dx.doi.org/10.18632/oncotarget.9356 |
Ejemplares similares
-
Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases
por: Mansinho, André, et al.
Publicado: (2019) -
Bone metastasis risk factors in breast cancer
por: Pulido, Catarina, et al.
Publicado: (2017) -
Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases
por: Ferreira, A.R., et al.
Publicado: (2017) -
Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?
por: Casimiro, Sandra, et al.
Publicado: (2016) -
Prevention of Nausea and Vomiting in Patients Undergoing Oral Anticancer Therapies for Solid Tumors
por: Costa, Ana Lúcia, et al.
Publicado: (2015)